CNS & Neurological Disorders - Drug Targets

Formerly Current Drug Targets - CNS & Neurological Disorders

Editor-in-Chief

Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria
Messina
(Italy)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 10 Issue: 6, September

Commentary [ Research Highlights(To miR or Not to miR: That is the Question in ALS Disease ]

Volume:10   Issue: 6
Pp: 648-649
Cinzia Volonte
DOI: 10.2174/187152711797247812
Published on: 01 March, 2012

Editorial [ Hot Topic: Drugs Targets in Parkinson's Disease:Where Are We and Where should We Go? (Guest Editor: Mark R. Cookson)]

Volume:10   Issue: 6
Pp: 650-650
Mark R. Cookson
DOI: 10.2174/187152711797247830
Published on: 01 March, 2012

Targeting Nicotinic Receptors for Parkinson's Disease Therapy

Volume:10   Issue: 6
Pp: 651-658
Maryka Quik, Tanuja Bordia, Luping Huang and Xiomara Perez
DOI: 10.2174/187152711797247849
Published on: 01 March, 2012

An Update on Adenosine A2A Receptors as Drug Target in Parkinson's Disease

Volume:10   Issue: 6
Pp: 659-669
Antoni Vallano, Víctor Fernandez-Duenas, Consuelo Pedros, Josep Maria Arnau and Francisco Ciruela
DOI: 10.2174/187152711797247803
Published on: 01 March, 2012

Current Options and Future Possibilities for the Treatment of Dyskinesia and Motor Fluctuations in Parkinson's Disease open access plus

Volume:10   Issue: 6
Pp: 670-684
M. A. Cenci, K. E. Ohlin and P. Odin
DOI: 10.2174/187152711797247885
Published on: 01 March, 2012

The Surgical Management of Parkinson's Disease

Volume:10   Issue: 6
Pp: 685-692
Francisco A. Ponce and Andres M. Lozano
DOI: 10.2174/187152711797247795
Published on: 01 March, 2012

Is rTMS an Effective Therapeutic Strategy that Can Be Used to Treat Parkinson's Disease?

Volume:10   Issue: 6
Pp: 693-702
Oscar Arias-Carrion, Sergio Machado, Flavia Paes, Bruna Velasques, Silmar Teixeira, Lizbeth Cardenas-Morales, Roberto Piedade, Pedro Ribeiro and Antonio E. Nardi
DOI: 10.2174/187152711797247821
Published on: 01 March, 2012

GDNF Family Ligands: A Potential Future for Parkinson's Disease Therapy

Volume:10   Issue: 6
Pp: 703-711
Amanda L. Mickiewicz and Jeffrey H. Kordower
DOI: 10.2174/187152711797247876
Published on: 01 March, 2012

Drug Targets from Genetics: Alpha-Synuclein

Volume:10   Issue: 6
Pp: 712-723
Karin M. Danzer and Pamela J. McLean
DOI: 10.2174/187152711797247867
Published on: 01 March, 2012

Kinases as Targets for Parkinson's Disease: From Genetics to Therapy

Volume:10   Issue: 6
Pp: 724-740
Renee Vancraenenbroeck, Evy Lobbestael, Marc De Maeyer, Veerle Baekelandt and Jean-Marc Taymans
DOI: 10.2174/187152711797247858
Published on: 01 March, 2012

Stem Cells in Stroke Repair: Current Success & Future Prospects

Volume:10   Issue: 6
Pp: 741-756
Renjitha Gopurappilly, Rajarshi Pal, Murali Krishna Mamidi, Sovan Dey, Ramesh Bhonde and Anjan Kumar Das
DOI: 10.2174/187152711797247894
Published on: 01 March, 2012

Chronic Cerebrospinal Venous Insufficiency (CCSVI) and Multiple Sclerosis (MS): A Critical Review

Volume:10   Issue: 6
Pp: 757-761
Chiara Zecca and Claudio Gobbi
DOI: 10.2174/187152711797247786
Published on: 01 March, 2012